PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,949,000 | +19.5% | 1,568,692 | +11.1% | 0.01% | -21.4% |
| Q2 2020 | $4,141,000 | +39.7% | 1,412,446 | +34.3% | 0.01% | +16.7% |
| Q1 2020 | $2,964,000 | -14.8% | 1,051,438 | -2.0% | 0.01% | -7.7% |
| Q4 2019 | $3,480,000 | +98.2% | 1,072,777 | +30.3% | 0.01% | +85.7% |
| Q3 2019 | $1,756,000 | -70.6% | 823,305 | -57.8% | 0.01% | -46.2% |
| Q2 2019 | $5,982,000 | +69.3% | 1,952,022 | +105.6% | 0.01% | -13.3% |
| Q1 2019 | $3,533,000 | +33.1% | 949,486 | +3.5% | 0.02% | +50.0% |
| Q4 2018 | $2,654,000 | +19.7% | 916,947 | +5.2% | 0.01% | +25.0% |
| Q3 2018 | $2,218,000 | +11.6% | 872,003 | +2.7% | 0.01% | +33.3% |
| Q2 2018 | $1,987,000 | -72.7% | 849,251 | -66.4% | 0.01% | +50.0% |
| Q1 2018 | $7,274,000 | +219.9% | 2,524,828 | +205.5% | 0.00% | 0.0% |
| Q4 2017 | $2,274,000 | -15.9% | 826,326 | +3.5% | 0.00% | -33.3% |
| Q3 2017 | $2,704,000 | +40.5% | 798,134 | +2.7% | 0.01% | +20.0% |
| Q2 2017 | $1,925,000 | +11.7% | 777,413 | +2.2% | 0.01% | +25.0% |
| Q1 2017 | $1,723,000 | +1235.7% | 760,340 | +1844.2% | 0.00% | – |
| Q1 2016 | $129,000 | -58.4% | 39,109 | -55.1% | 0.00% | -100.0% |
| Q4 2015 | $310,000 | -8.8% | 87,160 | +38.4% | 0.00% | 0.0% |
| Q3 2015 | $340,000 | -39.0% | 62,964 | -24.6% | 0.00% | -50.0% |
| Q2 2015 | $557,000 | +462.6% | 83,520 | +509.6% | 0.00% | – |
| Q1 2015 | $99,000 | -93.2% | 13,701 | -92.6% | 0.00% | -100.0% |
| Q4 2014 | $1,454,000 | -24.0% | 185,183 | -25.9% | 0.00% | -20.0% |
| Q3 2014 | $1,912,000 | +83.1% | 250,050 | +130.9% | 0.01% | – |
| Q2 2014 | $1,044,000 | -39.7% | 108,284 | -48.0% | 0.00% | -100.0% |
| Q1 2014 | $1,731,000 | -21.6% | 208,218 | -20.0% | 0.00% | -90.0% |
| Q4 2013 | $2,208,000 | +33.6% | 260,407 | +25.3% | 0.01% | 0.0% |
| Q3 2013 | $1,653,000 | +5.3% | 207,772 | +2.0% | 0.01% | -23.1% |
| Q2 2013 | $1,570,000 | +7.4% | 203,760 | +1.6% | 0.01% | -13.3% |
| Q1 2013 | $1,462,000 | +43.6% | 200,462 | +38.7% | 0.02% | +36.4% |
| Q4 2012 | $1,018,000 | – | 144,479 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |